standard 2 a 2
play

STANDARD 2/A.2 Clinical Partnerships and Practice Tatiana - PowerPoint PPT Presentation

STANDARD 2/A.2 Clinical Partnerships and Practice Tatiana Rivadeneyra, Ed.D. Accreditation Director, Site Visitor Development and EPP Accreditation Procedures Tatiana.Rivadeneyra@caepnet.org Washington, District of Columbia September 2017 T


  1. STANDARD 2/A.2 Clinical Partnerships and Practice Tatiana Rivadeneyra, Ed.D. Accreditation Director, Site Visitor Development and EPP Accreditation Procedures Tatiana.Rivadeneyra@caepnet.org Washington, District of Columbia September 2017 T R

  2. STANDARD 2 CLINICAL PARTNERSHIPS AND PRACTICE Washington, District of Columbia September 2017

  3. Session Overview • Of CAEP Initial-Licensure and Advanced-Level Standards 2/A.2. Including suggested evidence, evidence sufficiency criteria, and additional CAEP resources available. • Content will reference the evidence sufficiency criteria, handout. Fall 2017 | Washington, D.C.

  4. Standard 2/A.2’s Holistic Case That a strong collaborative clinical preparation is only as strong as the P- 12 partnerships, clinical educators (initial), and the clinical experiences. CAEP Standards for Initial-Licensure/Advanced-Level Programs , Evidence Sufficiency Criteria, Handout Fall 2017 | Washington, D.C.

  5. EVIDENCE SUFFICIENCY: RESOURCES CONSULT: • Evidence Sufficiency Criteria  Evaluation Criteria for Self-Study Evidence - Standard 2  CAEP Guidelines for Plans for phase-in plan content • 2017 SSRs can present plan with progress data • Site visits in F18 and beyond are not eligible for phase-in • Assessment Sufficiency Criteria  CAEP Evaluation Framework for EPP-Created Assessments Fall 2017 | Washington, D.C.

  6. Standard 2. Clinical Practice The provider ensures that effective partnerships [components 2.1 and 2.2] and high-quality clinical practice [component 2.3] are central to preparation so that candidates develop the knowledge, skills, and professional dispositions necessary to demonstrate positive impact on all P- 12 students’ learning and development. Fall 2017 | Washington, D.C.

  7. Rules for Standard 2 General for all Standards Special for Standard 2 • All components addressed • No required components • EPP-Created Assessments at CAEP level of sufficiency • At least 3 cycles of data • Cycles of data are sequential • Disaggregated data on candidates, for main/branch campuses Fall 2017 | Washington, D.C.

  8. Standard 2, Guidance from Component 2.1 Partners co-construct mutually beneficial P-12 school and community arrangements, including technology-based collaborations, for clinical preparation and share responsibility for continuous improvement of candidate preparation . Partnerships for clinical preparation can follow a range of forms, participants, and functions. They establish mutually agreeable expectations for candidate entry, preparation, and exit; ensure that theory and practice are linked ; maintain coherence across clinical and academic components of preparation; and share accountability for candidate outcomes. Consider : What evidence do I have that would demonstrate mutually beneficial and accountable partnerships in which decision-making is shared? Fall 2017 | Washington, D.C.

  9. Evidence Sufficiency Criteria, 2.1 EVIDENCE THAT A COLLABORATIVE PROCESS IN PLACE AND REVIEWED • Documentation provided for a shared responsibility model that includes elements of  Co-construction of instruments and evaluations  Co-construction of criteria for selection of mentor teachers  Involvement in on-going decision-making  Input into curriculum development  EPP and P-12 educators provide descriptive feedback to candidates  Opportunities for candidates to observe and implement effective teaching strategies linked to coursework Fall 2017 | Washington, D.C.

  10. Co-Construction of Clinical Experiences • Co-Construct the opportunities, challenges, and responsibilities, along with the support and guidance of clinical educators and designated faculty. • Co- Constructed opportunities allow Candidates to apply the knowledge, dispositions and skills developed in general education and professional courses. • Candidates should continue learning to adapt to the various conditions of classrooms in Co-Construction opportunities. Fall 2017 | Washington, D.C.

  11. Standard 2, Guidance from Component 2.2 Partners co-select , prepare , evaluate , support , and retain high-quality clinical educators , both provider- and school-based, who demonstrate a positive impact on candidates’ development and P -12 student learning and development . In collaboration with their partners, providers use multiple indicators and appropriate technology-based applications to establish, maintain, and refine criteria for selection , professional development , performance evaluation , continuous improvement , and retention of clinical educators in all clinical placement settings. Consider : What evidence do I have that would demonstrate the depth of partnership around highly effective clinical educators? Fall 2017 | Washington, D.C.

  12. Evidence Sufficiency Criteria, 2.2 EVIDENCE EPP AND P-12 CLINICAL EDUCATORS/ADMINISTRATORS CO- CONSTRUCT CRITERIA FOR CO- SELECTION • Clinical educators receive  Professional development, resources, and support  Are involved in creation of professional development opportunities, the use of evaluation instruments, professional disposition evaluation of candidates, specific goals/objectives of the clinical experience, and providing feedback  Data collected are used by EPPs and P-12 clinical educators for modification of selection criteria, future assignments of candidates, and changes in clinical experiences Fall 2017 | Washington, D.C.

  13. Clinical Educator Development/Responsibilities • Process of collaboration with partnerships; further demonstrate partnerships, in field-experiences  Developed - criteria, reflective teaching and learning, mutual engagement,…  Monitored - facilitate learning and development  Evaluated - opportunities for partners to… Fall 2017 | Washington, D.C.

  14. Standard 2, Guidance from Component 2.3 The provider works with partners to design clinical experiences of sufficient depth , breadth , diversity , coherence , and duration to ensure that candidates demonstrate their developing effectiveness and positive impact on all students’ learning and development. Clinical experiences, including technology-enhanced learning opportunities, are structured to have multiple performance-based assessments at key points within the program to demonstrate candidates’ development of the knowledge, skills, and professional dispositions, as delineated in Standard 1, that are associated with a positive impact on the learning and development of all P-12 students. Consider : What evidence do I have that clinical experiences develop candidates’ Knowledge, Skills, and Dispositions to have a positive impact on P-12 learning? Fall 2017 | Washington, D.C.

  15. Evidence Sufficiency Criteria, 2.3 EVIDENCE ALL CANDIDATES HAVE CLINICAL EXPERIENCES IN DIVERSE SETTINGS • Attributes (depth, breadth, diversity, coherence, and duration) are linked to student outcomes and candidate/completer performance documented in Standards 1 and 4  Evidence documents a sequence of clinical experiences that are focused, purposeful, and varied with specific goals  Clinical experiences include focused teaching experience where specific strategies are practiced  Clinical experiences are assessed using performance-based Fall 2017 | Washington, D.C.

  16. Clinical Experience Table Course Sample

  17. Clinical Experience Table Program Sample

  18. POTENTIAL ISSUES: Standard 2 AREAS FOR IMPROVEMENT MAY BE CITED WHEN: • Case:  Limited or no convincing evidence in any of the following that partnerships effectively co-select, prepare, evaluate, support or retain clinical faculty  An EPP fails to provide evidence, or provides limited evidence, that clinical experiences allow opportunities for the partners and the candidates to employ instructional uses of technology  There is no or only limited documentation that clinical experiences provide opportunities for candidates to engage diverse P-12 students Fall 2017 | Washington, D.C.

  19. POTENTIAL ISSUES: Standard 2 STIPULATIONS MAY BE CITED WHEN: • Case:  Limited or no substantial evidence that partnerships effectively share decision-making for expectations of candidates, coherence across clinical and academic components, and/or accountability for results  Limited or no evidence of monitoring in clinical experiences, of “positive impact on all P -12 students’ learning and development”  If there is evidence that clinical experiences provide limited or no opportunities for candidates to practice developing and improving their professional knowledge and skills through application in classroom situations Fall 2017 | Washington, D.C.

  20. STANDARD A.2 CLINICAL PARTNERSHIPS AND PRACTICE Washington, District of Columbia September 2017

  21. EVIDENCE SUFFICIENCY: RESOURCES CONSULT: • Evidence Sufficiency Criteria  Evaluation Criteria for Self-Study Evidence – Standard A.2  CAEP Guidelines for Plans for phase-in plan content • SSR submitted through academic year 2018/2019 can include plans for Components A.2 .1 and A.2.2 • 2019-2020 SSRs can present plan with progress data for Components A.2 .1 and A.2.2 • Site visits in F22 and beyond are not eligible for phase-in • Assessment Sufficiency Criteria  CAEP Evaluation Framework for EPP-Created Assessments Fall 2017 | Washington, D.C.

Recommend


More recommend